Back
Nomura Tax-Free USA Short Term ETF Vs. CRISPR Therapeutics AG Industry Stock Comparison
Buy
52
STAX
Nomura Tax-Free USA Short Term ETF
Last Price:
$25.50
Seasonality Move:
0.73%
Sell
43
CRSP
CRISPR Therapeutics AG
Last Price:
$55.24
Seasonality Move:
14.46%
Buy
52
Nomura Tax-Free USA Short Term ETF (STAX)
is a Buy
Is Nomura Tax-Free USA Short Term ETF a Buy, Sell or Hold?
-
The current Nomura Tax-Free USA Short Term ETF [STAX] share price is $25.48. The Score for STAX is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
-
STAX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
43
CRISPR Therapeutics AG (CRSP)
is a Sell
Is CRISPR Therapeutics AG a Buy, Sell or Hold?
-
The current CRISPR Therapeutics AG [CRSP] share price is $54.74. The Score for CRSP is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
-
CRSP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
STAX Stock Price Chart
What is Nomura Tax-Free USA Short Term ETF's stock price today?
-
The Nomura Tax-Free USA Short Term ETF share price today is $25.48Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and STAX is experiencing slight buying pressure.
CRSP Stock Price Chart
What is CRISPR Therapeutics AG's stock price today?
-
The CRISPR Therapeutics AG share price today is $54.74Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRSP is experiencing selling pressure, which indicates risk of future bearish movement.
STAX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.03 | Buy |
| Relative Strength Index (14 RSI): | 52.12 | Buy |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (25.45 - 25.49) | Buy |
| Bollinger Bands (100): | (25.46 - 25.6) | Sell |
CRSP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.25 | Sell |
| Relative Strength Index (14 RSI): | 45.45 | Sell |
| Chaikin Money Flow: | -1078798 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (51.55 - 56.85) | Buy |
| Bollinger Bands (100): | (52.52 - 65.44) | Sell |
STAX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 25.47 | Buy |
| 20-day SMA: | 25.47 | Buy |
| 50-day SMA: | 25.5 | Sell |
| 200-day SMA: | 25.4 | Buy |
| 8-day EMA: | 5.66 | Buy |
| 20-day EMA: | 2.43 | Buy |
| 50-day EMA: | 1 | Buy |
| 200-day EMA: | 0.25 | Buy |
CRSP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 56.72 | Sell |
| 20-day SMA: | 54.52 | Buy |
| 50-day SMA: | 59.78 | Sell |
| 200-day SMA: | 50.98 | Buy |
| 8-day EMA: | 56.04 | Sell |
| 20-day EMA: | 55.88 | Sell |
| 50-day EMA: | 56.44 | Sell |
| 200-day EMA: | 37.2 | Buy |
Nomura Tax-Free USA Short Term ETF Earnings Growth & STAX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
CRISPR Therapeutics AG Earnings Growth & CRSP Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.09 per share, and an increase next year of $1.74 per share.
Nomura Tax-Free USA Short Term ETF Technical Analysis
| Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
CRISPR Therapeutics AG Technical Analysis
| Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||